Aldeyra Therapeutics Inc (FRA:137) Stock News, Headlines & Updates
Aldeyra Therapeutics Inc Stock News from GuruFocus
- 1
Jun 13, 2024
Investigation Alert: Aldeyra, Eagle Pharmaceuticals, and Blue Ridge Bankshares: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
Marketwired • 11:00am
Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease
Business Wire • 7:00am
Jun 12, 2024
Aldeyra Therapeutics to Host Investor Roundtable Q&A
Business Wire • 7:00am
May 29, 2024
Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference
Business Wire • 7:00am
May 08, 2024
Aldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease
Business Wire • 7:00am
Apr 18, 2024
Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024
Business Wire • 7:00am
Mar 28, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news